Vanderbilt Kennedy Center Special Lecture: The Benefits and Risks of ADHD Medication: Evidence from Real-World Practice
Brian D'Onofrio, Ph.D., Sharon Stephens Brehm Endowed Professor, Department of Psychological and Brain Sciences, Indiana University
Monday, April 13, 2026, 12:00-1:00 p.m. CT
OMC 241, Vanderbilt Kennedy Center/One Magnolia Circle Building and online
A small number of lunches will be provided, first come, first served.
Attention-deficit/hyperactivity disorder (ADHD) is associated with significant impairment across the lifespan. ADHD treatment guidelines recommend pharmacotherapy based largely on highly controlled randomized controlled trials (RCTs). Yet, there are serious limitations of the existing RCTs that hinder the potential to apply an evidence-based approach to ADHD treatment. To help address these limitations and inform clinical care, this presentation will review evidence from large-scale observational studies leveraging national datasets and advanced epidemiologic designs.
For more information, call (615) 322-8240.